E-LIB Suche - Ergebnisse für: Rudick, Richard A.

1

Temporal Relationship Between Serum Neurofilament Light Cha..:

Fox, Robert J. ; Cree, Bruce A.C. ; de Sèze, Jérôme...
Neurology. 102 (2024) 9 - p. , 2024

2

Serum neurofilament light-chain levels and long-term treatm..:

Cutter, Gary ; Rudick, Richard A ; de Moor, Carl...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 9 (2023) 2 - p. 205521732311694 , 2023

Link: https://doi.org/10.1177/..

3

Epsilon toxin–producing Clostridium perfringens colonize th..:

Ma, Yinghua ; Sannino, David ; Linden, Jennifer R....
Journal of Clinical Investigation. 133 (2023) 9 - p. , 2023

Link: https://doi.org/10.1172/..

4

Magnetic resonance fingerprinting in multiple sclerosis:

Ontaneda, Daniel ; Gulani, Vikas ; Deshmane, Anagha...
Multiple Sclerosis and Related Disorders. 79 (2023) - p. 105024 , 2023

Link: https://doi.org/10.1016/..

5

Real-world effectiveness of dimethyl fumarate versus fingol..:

Hersh, Carrie M ; Altincatal, Arman ; Belviso, Nicholas...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8 (2022) 1 - p. 205521732110698 , 2022

Link: https://doi.org/10.1177/..

6

Associations of sNfL with clinico‐radiological measures in ..:

Sotirchos, Elias S. ; Fitzgerald, Kathryn C. ; Singh, Carol M....
Annals of Clinical and Translational Neurology. 10 (2022) 1 - p. 84-97 , 2022

Link: https://doi.org/10.1002/..

7

Development of a Highly Sensitive Neurofilament Light Chain..:

Lee, Stephen ; Plavina, Tatiana ; Singh, Carol M....
Frontiers in Neurology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

8

Benefits of early treatment with natalizumab: a real-world ..:

Ontaneda, Daniel ; Mowry, Ellen M. ; Newsome, Scott D...
Multiple Sclerosis and Related Disorders. 68 (2022) - p. 104216 , 2022

Link: https://doi.org/10.1016/..

9

Quantitative signal properties from standardized MRIs corre..:

Brier, Matthew R. ; Snyder, Abraham Z. ; Tanenbaum, Aaron...
Annals of Clinical and Translational Neurology. 8 (2021) 5 - p. 1096-1109 , 2021

Link: https://doi.org/10.1002/..

10

Impact of natalizumab on quality of life in a real-world co..:

Hersh, Carrie M ; Kieseier, Bernd ; Moor, Carl de...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 7 (2021) 2 - p. 205521732110046 , 2021

Link: https://doi.org/10.1177/..

11

Impact du natalizumab sur la qualité de vie d'une cohorte e..:

Hersh, Carrie M. ; Kieseier, Bernd ; De Moor, Carl...
Revue Neurologique. 177 (2021) - p. S126 , 2021

Link: https://doi.org/10.1016/..

12

Measuring treatment response to advance precision medicine ..:

Calabresi, Peter A. ; Kappos, Ludwig ; Giovannoni, Gavin...
Annals of Clinical and Translational Neurology. 8 (2021) 11 - p. 2166-2173 , 2021

Link: https://doi.org/10.1002/..

13

Impact of Natalizumab on Quality of Life in a Real-World Co..:

Hersh, Carrie M. ; Kieseier, Bernd ; de Moor, Carl...
Neurology. 96 (2021) 15_supplement - p. , 2021

Link: https://doi.org/10.1212/..

14

Serum neurofilament light-chain (sNfL) levels and long-term..:

Cutter, Gary ; Rudick, Richard A. ; De Moor, Carl...
Neurology. 96 (2021) 15_supplement - p. , 2021

Link: https://doi.org/10.1212/..

15

Harnessing Real-World Data to Inform Decision-Making: Multi..:

Mowry, Ellen M. ; Bermel, Robert A. ; Williams, James R....
Frontiers in Neurology. 11 (2020) - p. , 2020

Link: https://doi.org/10.3389/..